These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7522514)

  • 21. Upregulation of DAF (CD55) on orbital fibroblasts by cytokines. Differential effects of TNF-beta and TNF-alpha.
    Cocuzzi ET; Bardenstein DS; Stavitsky A; Sundarraj N; Medof ME
    Curr Eye Res; 2001 Aug; 23(2):86-92. PubMed ID: 11840345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role and regulation of pig CD59 and membrane cofactor protein/CD46 expressed on pig aortic endothelial cells.
    van den Berg CW; Rix C; Hanna SM; Perez de la Lastra JM; Morgan BP
    Transplantation; 2000 Aug; 70(4):667-73. PubMed ID: 10972227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-beta isoforms regulate the surface expression of membrane cofactor protein (CD46) and CD59 on human keratinocytes [corrected].
    Pasch MC; Bos JD; Daha MR; Asghar SS
    Eur J Immunol; 1999 Jan; 29(1):100-8. PubMed ID: 9933091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement regulatory proteins in early human fetal life: CD59, membrane co-factor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver.
    Simpson KL; Houlihan JM; Holmes CH
    Immunology; 1993 Oct; 80(2):183-90. PubMed ID: 7505254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
    Terstappen LW; Nguyen M; Lazarus HM; Medof ME
    J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
    Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
    J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
    Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
    Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
    Brodbeck WG; Mold C; Atkinson JP; Medof ME
    J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of thyroid cancer cells by complement-regulatory factors.
    Yamakawa M; Yamada K; Tsuge T; Ohrui H; Ogata T; Dobashi M; Imai Y
    Cancer; 1994 Jun; 73(11):2808-17. PubMed ID: 7514955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.
    Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I
    Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
    Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
    Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation/inactivation of the classical pathway of complement in non-lesional skin of patients with systemic lupus erythematosus.
    Alahlafi A; Wordsworth P; Wojnarowska F
    J Cutan Pathol; 2005 Sep; 32(8):537-40. PubMed ID: 16115051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis.
    Uesu T; Mizuno M; Inoue H; Tomoda J; Tsuji T
    Lab Invest; 1995 May; 72(5):587-91. PubMed ID: 7538183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenovirus-mediated triple gene transfer of human complement regulating proteins to the porcine endothelial cell.
    Nagahama M; Shiraishi M; Oshiro T; Muto Y
    Transplant Proc; 2000 Nov; 32(7):2511-3. PubMed ID: 11120272
    [No Abstract]   [Full Text] [Related]  

  • 35. CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions.
    Seifert PS; Roth I; Schmiedt W; Oelert H; Okada N; Okada H; Bhakdi S
    Atherosclerosis; 1992 Oct; 96(2-3):135-45. PubMed ID: 1281630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement-binding proteins are strongly expressed by human preimplantation blastocysts and cumulus cells as well as gametes.
    Taylor CT; Johnson PM
    Mol Hum Reprod; 1996 Jan; 2(1):52-9. PubMed ID: 9238658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VCAM-1 expression on endothelium in lesions from cutaneous lupus erythematosus is increased compared with systemic and localized scleroderma.
    Jones SM; Mathew CM; Dixey J; Lovell CR; McHugh NJ
    Br J Dermatol; 1996 Nov; 135(5):678-86. PubMed ID: 8977665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
    Lublin DM; Coyne KE
    J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
    Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
    J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.